Algorithm that performs as accurately as dermatologists
A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics. With an algorithm they devised themselves, scientists at the University of Gothenburg show the capacity of technology to perform at the same level as dermatologists in assessing the severity of skin melanoma.
The study, published in the Journal of the American Academy of Dermatology, and its results are the work of a research group at the Department of Dermatology and Venereology at Sahlgrenska Academy, University of Gothenburg.
The study was conducted at Sahlgrenska University Hospital in Gothenburg. Its purpose was, through machine learning (ML), to train an algorithm to determine whether skin melanoma is invasive and there is a risk of it spreading (metastatizing), or whether it remains at a growth stage in which it is confined to the epidermis, with no risk of metastasis.
The algorithm was trained and validated on 937 dermatoscopic images of melanoma, and subsequently tested on 200 cases. All the cases included were diagnosed by a dermatopathologist.
Algorithm vs dermatologist
The majority of melanomas are found by patients rather than doctors. This suggests that, in most cases, diagnosis is relatively easy. Before surgery, however, it is often much more difficult to determine the stage the melanoma has reached.
To make the classifications more accurate, dermatologists use dermatoscopes — instruments that combine a type of magnifying glass with bright illumination. In recent years, interest in using ML for skin tumor classifications has increased, and several publications have shown that ML algorithms can perform on par with, or even better than, experienced dermatologists.
The current study is now giving a further boost to research in this field. When the same classification task was performed by the algorithm on the one hand and seven independent dermatologists on the other, the result was a draw.
Support for patients and doctors
“None of the dermatologists significantly outperformed the ML algorithm,” states Sam Polesie, a researcher at the University of Gothenburg and specialist doctor at Sahlgrenska University Hospital, who is the corresponding author of the study.
In a developed form, the algorithm could serve as support in the task of assessing the severity of skin melanoma before surgery. The classification affects how extensive an operation needs to be, and is therefore important for both the patient and the surgeon.
“The results of the study are interesting, and the hope is that the algorithm can be used as clinical decision support in the future. But it needs refining further, and prospective studies that monitor patients over time are necessary, too,” Polesie concludes.
Original Article: Algorithm that performs as accurately as dermatologists
More from: University of Gothenburg
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Skin cancer diagnostics
- Increasing Incidences of Skin Cancer to Drive Demand for Melanoma Cancer Diagnostics Through 2028on April 11, 2021 at 8:34 pm
Spending on advanced and safe melanoma cancer diagnostics is growing in the US, as efforts to diagnose the disease at an early stage gain traction. The American Academy of Dermatology estimates around ...
- MP’s cervical cancer diagnosis a wake-up callon April 11, 2021 at 10:00 am
OPINION: I was very sad to hear the news that cabinet minister and East Coast MP Kiri Allan has been diagnosed with stage three cervical cancer. If you don’t know where the cervix is, it’s the small ...
- Woman who is allergic to sunlight diagnosed with skin cancer for 28th timeon April 11, 2021 at 1:16 am
Despite doing everything she can to protect herself, the condition has already caused her to develop skin cancer 28 times and she says it has forced her into menopause iat 23. The blogger from ...
- Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancerson April 9, 2021 at 4:01 am
Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were not able to have their tumors surgically removed. The drug combination is ...
- Sen. Thom Tillis Recovering After Surgery for Canceron April 8, 2021 at 11:14 am
North Carolina Sen. Thom Tillis is recovering after surgery for prostate cancer, he said in a statement Thursday. The second-term Republican went public with his cancer diagnosis last week. “As I ...
Go deeper with Google Headlines on:
Skin cancer diagnostics
Go deeper with Bing News on:
Artificial intelligence diagnostics
- FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Canceron April 9, 2021 at 3:05 pm
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting ...
- BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)on April 9, 2021 at 6:32 am
Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to date to collaborate on developing novel solutions to improve the quality of care and reduce failure ratesThe Company ...
- Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistanceon April 8, 2021 at 7:51 am
Diagnosis using artificial intelligence (AI) with deep learning could be useful ... The other set was the same as the first set but included the diagnostic real-time assistance of AI, with the AI ...
- SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Softwareon April 8, 2021 at 12:01 am
KUALA LUMPUR, Malaysia, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI ... of medical professionals with its comprehensive AI-powered chest diagnostic solutions ...
- Artificial intelligence powered nanosensors to explore the biomolecular worldon April 7, 2021 at 8:25 am
Their innovative technique uses nanotechnology, metasurfaces, infrared light and artificial intelligence. The team’s research ... and pharmacology – from fundamental research and disease diagnostics ...